logo
Loading...
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCESO1 trial
Medicine and HealthNature Medicine

Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCESO1 trial

J. Qin, L. Xue, et al.

This groundbreaking phase 3 trial evaluates the combination of neoadjuvant camrelizumab with chemotherapy against chemotherapy alone in patients with locally advanced esophageal squamous cell carcinoma. Notably, it demonstrates superior pathological complete response rates, paving the way for innovative treatment options. The research was conducted by an extensive team of experts from leading institutions.... show more
Introduction
Literature Review
Methodology
Key Findings
Discussion
Conclusion
Limitations
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 22+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny